Relationship between phase I study duration and symptom burden.

about

Relationship between phase I study duration and symptom burden.

Item

http://www.wikidata.org/entity/Q49589187

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Relationship between phase I study duration and symptom burden.

@en

Relationship between phase I study duration and symptom burden.

@nl

type

Item

label

Relationship between phase I study duration and symptom burden.

@en

Relationship between phase I study duration and symptom burden.

@nl

prefLabel

Relationship between phase I study duration and symptom burden.

@en

Relationship between phase I study duration and symptom burden.

@nl

P1476

Relationship between phase I study duration and symptom burden.

@en

P2093

Afshin Dowlati

http://www.w3.org/2001/XMLSchema#string

Barbara Daly

http://www.w3.org/2001/XMLSchema#string

Michelle Treasure

http://www.w3.org/2001/XMLSchema#string

Neal J Meropol

http://www.w3.org/2001/XMLSchema#string

Pingfu Fu

http://www.w3.org/2001/XMLSchema#string

Svetoslava Kerpedjieva

http://www.w3.org/2001/XMLSchema#string

P2860

The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease.

Is race/ethnicity related to the presence or severity of pain in colorectal and lung cancer?

Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Symptom burden: multiple symptoms and their impact as patient-reported outcomes.

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

Patient-reported outcomes assessment in cancer trials: taking stock, moving forward.

The prognostic significance of patient-reported outcomes in cancer clinical trials.

Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.

P2888

s00520-017-3879-1

P304

731-737

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-017-3879-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28980072

http://www.w3.org/2001/XMLSchema#string